"Fructose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.
| Descriptor ID |
D005632
|
| MeSH Number(s) |
D09.947.875.359.250 D09.947.875.465.354
|
| Concept/Terms |
Apir Levulosa- Apir Levulosa
- Levulosa, Apir
- Levulosa Mein
- Plast Apyr Levulosa Mein
- Levulosa Ibys
|
Below are MeSH descriptors whose meaning is more general than "Fructose".
Below are MeSH descriptors whose meaning is more specific than "Fructose".
This graph shows the total number of publications written about "Fructose" by people in this website by year, and whether "Fructose" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1999 | 2 | 2 | 4 |
| 2003 | 1 | 2 | 3 |
| 2004 | 2 | 1 | 3 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 0 | 2 | 2 |
| 2013 | 3 | 1 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fructose" by people in Profiles.
-
Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release. Diabetes Care. 2017 07; 40(7):856-862.
-
Epilepsy update, part 2: nursing care and evidence-based treatment. Am J Nurs. 2015 Jun; 115(6):34-44; quiz 45-6.
-
Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care. 2014 Dec; 37(12):3309-16.
-
Headache and the pseudotumor cerebri syndrome. Curr Pain Headache Rep. 2014 Sep; 18(9):446.
-
Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trials. J Stud Alcohol Drugs. 2014 Mar; 75(2):335-46.
-
Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care. 2014 Apr; 37(4):912-21.
-
Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management. Expert Opin Drug Saf. 2013 Sep; 12(5):741-56.
-
Pharmacotherapy of obesity: clinical treatments and considerations. Am J Med Sci. 2013 Apr; 345(4):284-288.
-
Prevalence and spot urine risk factors for renal stones in children taking topiramate. J Pediatr Urol. 2013 Dec; 9(6 Pt A):884-9.
-
Bitter taste inhibiting agents for whey protein hydrolysate and whey protein hydrolysate beverages. J Food Sci. 2012 Aug; 77(8):S282-7.